Cardiovascular Disease (CVD) Risk in Women With Endometriosis: A Comprehensive Meta-Analysis

Maneeth Mylavarapu, Samuel J, Jeffry Samuel, Ravitej Thandi, Thandi R, Rizwan Mubashir, Mubashir R, Vaishnavi Reddy Veeranagari, Veeranagari VR, Barakat A, Aly Barakat, Neto JFB, Joao Ferreira de Barros Neto, Alaa Osman, Osman A, Sudeeshna Thiyagarajan, Thiyagarajan S, Mohamed R, Reem Mohamed, Hassan MJ, Muhammad Junaid Hassan
Clinical cardiology · 2026 · vol. 49(8) , pp. e70443 · doi:10.1002/clc.70443 · PMID:42578681 · PMC13459647 · W7202181424
meta-analysis OA: gold CC-BY-4.0
📄 Open PDF View on OpenAlex View on PubMed View at publisher

Abstract

BACKGROUND: Cardiovascular disease (CVD) remains the leading cause of mortality globally. Emerging evidence indicates that cardiovascular risk in women is frequently underestimated, underscoring the importance of recognizing sex-specific contributors. Endometriosis is a chronic inflammatory disorder affecting 5%-10% of reproductive-aged women. However, previous syntheses evaluating its cardiovascular implications have yielded inconsistent results or were narrow in scope. METHODS: A systematic literature search was conducted across databases, adhering to PRISMA guidelines. Studies comparing cardiovascular outcomes in women with versus without endometriosis were included. Primary outcomes were overall CVD and major adverse cardiovascular events (MACE). Secondary outcomes included ischemic heart disease (IHD), coronary artery disease (CAD), heart failure (HF), arrhythmias, coronary revascularization, and a composite of angina/acute myocardial infarction (Angina-AMI). Random-effects models with inverse variance weighting were used to calculate risk ratios (RRs) and 95% confidence intervals (CIs). RESULTS: Women with endometriosis exhibited a significantly higher risk of primary outcomes, including overall CVD (RR 1.21; 95% CI 1.09-1.35; p = 0.004) and MACE (RR 1.23; 95% CI 1.10-1.38; p = 0.01). Regarding secondary outcomes, endometriosis was significantly associated with elevated risks of IHD (RR 1.57; 95% CI 1.14-2.17; p = 0.01), CAD (RR 1.36; 95% CI 1.32-1.41; p < 0.0001), and Angina-AMI (RR 1.62; 95% CI 1.18-2.21; p = 0.002). Moderate-to-high statistical heterogeneity was observed across most secondary endpoints, except for CAD. CONCLUSION: Endometriosis is significantly associated with an increased risk of overall CVD, MACE, and ischemic coronary complications. These findings suggest that endometriosis should be recognized as an important sex-specific modifier of cardiovascular risk.

My notes (saved in your browser only)

MeSH descriptors

Cardiovascular Diseases Cardiovascular Diseases Cardiovascular Diseases Cardiovascular Diseases Cardiovascular Diseases Cardiovascular Diseases Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Female Female Female Global Health Global Health Global Health Heart Disease Risk Factors Heart Disease Risk Factors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (55)

Source provenance

europepmc
last seen: 2026-08-14T06:11:53.302379+00:00
openalex
last seen: 2026-08-14T06:05:18.289012+00:00
pubmed
last seen: 2026-08-14T06:07:03.485594+00:00
unpaywall
last seen: 2026-08-12T06:43:03.944938+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine